UnitedHealth keeps plunging as Washington cracks down on Medicare Advantage fraud

UnitedHealth shares fell 7.1% on Thursday and are down 20.1% in five days after the government proposed sweeping new audits of Medicare Advantage billing, including reviews that reach back to 2018.

AI illustration for this news story: UnitedHealth keeps plunging as Washington cracks down on Medicare Advantage fraud
AI-generated illustration, not a photo.

A brutal week for the biggest Medicare Advantage insurer

UnitedHealth's stock tumbled again on Thursday, falling 7.1% in afternoon trading, as the government pledged to crack down on fraud in the Medicare Advantage program and lawmakers renewed a call for Medicare for All, MarketWatch reported. The shares have plunged 20.1% over the last five days, alongside a widespread selloff of health-insurance and biopharma stocks.

Health insurer shares fell across the board Tuesday and Wednesday. UnitedHealth ended Wednesday's session down 10.2%, to $349.91. CVS Health fell 5.2% to $81.35, and Humana declined 13%, closing at $385.78, Barron's reported.

The selloff, in numbersSource: MarketWatch, Barron's
  • Thursday moveDown 7.1%
  • Five-day dropDown 20.1%
  • Wednesday close$349.91 (down 10.2%)
  • Humana WednesdayDown 13% to $385.78
  • CVS WednesdayDown 5.2% to $81.35
  • CMS savings estimateAbout $90 billion over 10 years
  • Audits reach back toPayment year 2018

The CRUSH rule: audits that reach back to 2018

The trigger is a proposal from the Centers for Medicare and Medicaid Services, the agency that runs Medicare. On Monday, November 16, the agency released a proposed rule to expand the scope of government audits of Medicare Advantage health plans, which are operated by private insurers, Barron's reported. Officials say taxpayers could save about $90 billion over 10 years under the proposal, which the Medicare agency calls CRUSH, or Comprehensive Regulations to Uncover Suspicious Healthcare.

Part of CRUSH would enable the government to extrapolate findings from audit samples to entire health plan contracts in order to recover improper payments dating back to payment year 2018, Barron's reported. "The core component of a RADV audit is to ensure that all diagnoses are properly supported by medical records," the agency said in the proposal, referring to risk adjustment data validation. Oppenheimer analysts noted that nearly the entire $90 billion savings amount reflects recoveries from Medicare Advantage plans, rather than savings spread across federal health care programs.

The ultimate financial impact remains uncertain and subject to final rulemaking and potential litigation, Mizuho Securities said in a client note, adding that the proposal will be an important area to watch for companies with meaningful Medicare Advantage exposure, including Humana, UnitedHealth and CVS. Oppenheimer's Michael Wiederhorn wrote that if CRUSH were implemented, insurers could price the exposure into bids in future years to preserve margins, Barron's reported.

A second front: Medicare for All

Then on Wednesday, Senator Bernie Sanders, the Vermont Independent, outlined plans to push for Medicare for All health coverage in the next Congress, according to an interview with the Associated Press, Barron's reported. Chris Meekins, a Washington health care policy analyst with Raymond James, said news on both fronts appeared to be hitting the health insurance sector, but suggested in a client note that private insurance may not be impacted by Medicare for All policy ideas to the extent investors fear.

"These proposals are materially different from immediately eliminating private insurance and immediately moving provider reimbursement toward Medicare rates," Meekins wrote Wednesday, Barron's reported.

Humana said it had no comment on the proposal, and UnitedHealth didn't comment, Barron's reported. A CVS spokesperson said the company didn't have a specific comment on CRUSH, adding: "we are confident in our risk-adjustment program and practices, including how we submit, audit and review codes." A spokesman for health insurer trade association AHIP said it is "closely reviewing the proposed rule," adding that health plans share the goal of combating waste, fraud and abuse while ensuring Medicare Advantage continues to provide better care at lower costs for the 36 million Americans who choose it.

A modern hospital building exterior with glass facade in daylight
AI-generated illustration, not a photo.

A proposal, not a final rule

The proposal is just that: a proposal, not a final rule. Its final impact depends on the rulemaking process and any litigation that follows, and the comment period and court challenges could stretch well into 2027. Until then, investors are pricing in a risk they cannot yet measure.

For now, the market has spoken first: five days of selling have cut about a fifth off the shares of the sprawling health care conglomerate, and the sector's fate now turns on how far Washington is willing to go. This article is general market commentary, not investment advice.

Sources

Educational content, not investment advice. Facts as of the publish time above; figures come from the linked sources and markets change quickly. Genexus Alpha is not a registered investment adviser or broker.